JCR Pharmaceuticals and Modalis Therapeutics have advanced to the next phase of their joint research agreement, focusing on developing a novel gene therapy for a central nervous system disease.

JCR Pharmaceuticals and Modalis Therapeutics have advanced their joint research agreement to the next phase, focusing on the development of a novel gene therapy for a central nervous system disease.

Preity Zinta and her husband Gene Goodenough are celebrating the New Year in Uruguay, South America. The couple recently visited La Mano and shared pictures from their trip on Instagram.

Dec. 10, 2024 — In a single IV injection, a gene therapy targeting cBIN1 can reverse the effects of heart failure and restore heart function in a large animal model. The therapy increases the ...

It seeks to understand the process of trait inheritance from parents to offspring, including the molecular structure and function of genes, gene behaviour in the context of a cell or organism (e.g ...

The authors develop and validate mFISHseq, a spatially informed assay that tackles several unmet needs in breast cancer, including discordance in molecular subtyping and prognostic risk and ...

New Gene Therapy Reverses Heart Failure in Large Animal Model Dec. 10, 2024 — In a single IV injection, a gene therapy targeting cBIN1 can reverse the effects of heart failure and restore heart ...

Cutting-edge framework deciphers the complexities of gene expression, linking molecular insights to patient survival and paving the way for personalized cancer treatments. Research: Deep profiling of ...